$ASPI Balance Sheet | Understand Stock

$ASPI

$2.08 +$0.06 (2.72%) Live

$ASPI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2022 As of Nov 30, 2022
Assets
Current assets:
Cash
Cash and cash equivalents
Short-term investments
Restricted cash
Accounts Receivable
Inventories
Receivable from noncontrolling interests
Note receivable
Lease receivable - current
Deferred offering costs
Prepaid expenses and other current assets
Current assets of discontinued operations
Total current assets

Property and equipment, net
Natural gas properties
Operating lease right-of-use assets, net
Deferred tax assets
Intangible assets
Goodwill
Lease receivable - noncurrent
Restricted cash
Equity method investments
Other investments
Other noncurrent assets
Noncurrent assets of discontinued operations
Total assets
Liabilities and stockholders' equity
Current liabilities:
Accounts payable
Accrued expenses
Notes payable - current
Debt - current
Finance lease liabilities - current
Operating lease liabilities - current
Deferred revenue
Due to related parties
Other current liabilities
Share liability
Current liabilities of discontinued operations
Total current liabilities
Deferred tax liabilities
Convertible notes payable, at fair value
Debt - noncurrent
Finance lease liabilities - noncurrent
Operating lease liabilities - noncurrent
Deferred revenue - noncurrent
Other noncurrent liabilities
Noncurrent liabilities of discontinued operations
Total liabilities
Stockholders' equity
Preferred stock, $0.01 par value; 10,000,000 shares authorized, no shares issued and outstanding as of June 30, 2026 and December 31, 2025
Common stock, $0.01 par value; 500,000,000 shares authorized, 130,284,092 shares issued and 130,148,698 shares outstanding as of June 30, 2026 and 111,677,771 shares issued and outstanding as of December 31, 2025
Treasury stock at cost
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Total stockholders' equity attributed to ASP Isotopes Inc. stockholders
Noncontrolling interests in consolidated subsidiaries
Total stockholders' equity
Total liabilities and stockholders' equity

Comments